regulus therapeutics inc
(RGLS:Consolidated Issue listed on NASDAQ Global Market)
David P. Bartel Ph.D.
Member of Scientific Advisory Board, Regulus Therapeutics Inc.
|Age||Total Calculated Compensation||This person is connected to 27 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. David P. Bartel, Ph.D. serves as an Associate Professor at Whitehead Institute for Medical Research. Dr. Bartel serves as a Member of Scientific Advisory Board at Alnylam Pharmaceuticals Inc., Firefly BioWorks, Inc. and Regulus Therapeutics Inc. Dr. Bartel, Professor of Biology at MIT, Howard Hughes Medical Institute investigator and member of the Whitehead Institute. Dr. Bartel has made major contributions to recent advances in understanding the role of micro-RNAs ...
3545 John Hopkins CourtPhone: 858-202-6300
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|$580.0K||Compensation as of Fiscal Year 2013.|